1. 1. Ministry of Internal Affairs and Communications of Japan. Challenges posed by super aged society. http://www.soumu.go.jp/johotsusintokei/whitepaper/ja/h25/html/nc123120.html (accessed June 16, 2019).
2. 2. Sekimoto K, Abe K, Yamazaki M. Comparative study of pharmaceutical additives and effects of these on sense of use between brand-name and generic tapes. Pharmacomet. 2013; 85:83-89. (in Japanese)
3. 3. Miura T, Matsuzaki H, Nouno H. Questions from patients: adhesiveness of percutaneous bronchodilator delivery system tulobuterol. Jpn Ambul Gene Pediat. 2008; 11:14-19. (in Japanese)
4. 4. Voltaren® tape interview form: March 2015 (revised 8th edition).
5. 5. Ito K, Masuda N, Sugimura S, Fujii C, Miyazaki A, Oguchi M, Onotogi M, Yotsuzuka F. Assessment of the anti-inflammatory and analgesic effect of Voltaren® tape (1% diclofenac-sodium tape) vs. 3.5% or 0.5% felbinac tape and 3.75% lndomethacin tape. Jpn Pharmacol Ther. 2009; 37:1015-1023. (in Japanese)